摘要
异戊二烯代表了植物化学物质中最大类别之一。这些化合物多样的结构以及显著的生物活性使得他们成为新型治疗剂的合适候选。许多异戊二烯在调制血管发生过程已经阐释了确定的潜能,因此提供一个有吸引力的替代和/或添加到可用的药物疗法。这些化合物可以单独使用或者与标准治疗法结合使用,这样可能能够减少不希望的副作用的影响。像倍半萜青蒿素,及其衍生物,或者二萜雷公藤化合物已在广泛的模型中(体外和体内)试验成功。此外,倍半萜类看起来是自然的血管生成调节剂的有前途的资源,因为它可以由最近的这个课题出版物的显著数目上被证明。另一方面,其他的异戊二烯,如三萜熊果酸,仍在探索且还需要进一步研究,以了解其在血管生成过程中的角色。进一步了解异戊二烯在血管生成中的作用模式将有希望开辟一条通向临床使用成功的道路。
关键词: 血管生成,天然产物,单帖,倍半萜,二萜,三萜,四萜。
Current Medicinal Chemistry
Title:Role of Isoprenoid Compounds on Angiogenic Regulation: Opportunities and Challenges
Volume: 23 Issue: 9
Author(s): Angela R. Guerra, Iola F. Duarte, Maria F. Duarte
Affiliation:
关键词: 血管生成,天然产物,单帖,倍半萜,二萜,三萜,四萜。
摘要: Isoprenoids represent one of the largest classes of phytochemicals. The structural diversity of these compounds, as well as their remarkable biological activities, makes them suitable candidates for the development of novel therapeutic agents. Several isoprenoids have demonstrated promising potential in the modulation of angiogenesis processes, and therefore provide an appealing alternative and/or addition to the available pharmacotherapies. These compounds could be used per se or combined with standard therapies, which can potentially reduce the undesired secondary effects. Compounds like the sesquiterpenoid artemisinin, and its derivatives, or the diterpenoid triptolide have been successfully tested in a broad range of models (in vitro and in vivo). Moreover, sesquiterpenoids seem to be a promising resource of natural angiogenic modulators, as it can be attested by the significant number of recent publications in this subject. On the other hand, other isoprenoids, such as the triterpenoid ursolic acid, are still under-explored and further studies are needed to understand their role within angiogenic process. Further insights into isoprenoids mode of action in angiogenesis will hopefully pave the way towards their successful clinical use.
Export Options
About this article
Cite this article as:
Angela R. Guerra, Iola F. Duarte, Maria F. Duarte , Role of Isoprenoid Compounds on Angiogenic Regulation: Opportunities and Challenges, Current Medicinal Chemistry 2016; 23 (9) . https://dx.doi.org/10.2174/0929867323666160217123822
DOI https://dx.doi.org/10.2174/0929867323666160217123822 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chronic Latent Magnesium Deficiency in Obesity Decreases Positive Effects of Vitamin D on Cardiometabolic Risk Indicators
Current Vascular Pharmacology Impact of Exercise Training on Physiological Measures of Physical Fitness in the Elderly
Current Aging Science Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?
Current Cardiology Reviews The Role of Platelets in Bone Remodeling
Inflammation & Allergy - Drug Targets (Discontinued) Anti-TNF Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Mediterranean Diet and Longevity
Current Nutrition & Food Science Memory Impairment is Associated with Serum Methylarginines in Older Adults
Current Alzheimer Research Squalene as Novel Food Factor
Current Pharmaceutical Biotechnology Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review
Current Molecular Pharmacology Inflammation and Chronic Heart Failure: From Biomarkers to Novel Anti-inflammatory Therapeutic Strategies
Medicinal Chemistry The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins
Current Pharmaceutical Design Realising Heart Regeneration
Current Tissue Engineering (Discontinued) The Effect of Chronic Co-Administration of Morphine and Verapamil on Isoproterenol-Induced Heart Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition
Current Drug Targets Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies Cysteine Network (CYSTEINET) Dysregulation in Parkinson’s Disease: Role of N-acetylcysteine
Current Drug Metabolism Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease
Current Vascular Pharmacology Chips for Brains
Current Genomics Naringenin and Atherosclerosis: A Review of Literature
Current Pharmaceutical Biotechnology Impact of MCP -1 in Atherosclerosis
Current Pharmaceutical Design